Blog
RSS FeedPosted by Michael Wonder on 27 Nov 2022
The cruellest tax: clipping the ticket on unfunded cancer drugs
28 November 2022 - Jo McKenzie-McLean’s life was turned upside down after a stage 4 bowel cancer diagnosis. ...
Posted by Michael Wonder on 21 Nov 2022
Kiwi myeloma cancer sufferers don’t have access to daratumumab, a drug available in Australia
21 November 2022 - Kiwi cancer sufferers are being denied a drug that saves lives in other countries, including Australia ...
Posted by Michael Wonder on 20 Nov 2022
PHARMAC welcomes Myeloma NZ as first patient advocacy group to present to PTAC
21 November 2022 - Myeloma New Zealand presented directly to PHARMAC’s Pharmacology and Therapeutics Advisory Committee (PTAC) on Thursday, making ...
Posted by Michael Wonder on 06 Nov 2022
Woman who has to pay $115k for unfunded cancer drug asks: 'What price is a life?'
5 November 2022 - More than anything, Annemarie Hope-Cross wants to live. ...
Posted by Michael Wonder on 05 Oct 2022
New PHARMAC funded drug will help in the cancer battle - but it's still not enough
5 October 2022 - Lung Foundation New Zealand CEO Philip Hope says funding by PHARMAC of a new cancer drug is ...
Posted by Michael Wonder on 24 Sep 2022
Prostate cancer: Tauranga man spends $212,000 on treatment
24 September 2022 - Five thousand and five hundred dollars every 28 days - more than $200,000 so far. ...
Posted by Michael Wonder on 14 Sep 2022
PHARMAC announces medicines bundle to provide more treatment options for New Zealanders
14 September 2022 - PHARMAC is considering funding two medicines as part of a new bundle agreement that would offer ...
Posted by Michael Wonder on 12 Sep 2022
Blood cancer patient charity campaigns for PHARMAC to fund medicine
12 September 2022 - Blood cancer patients are urging PHARMAC to fund a medicine that would restore the quality of life ...
Posted by Michael Wonder on 08 Sep 2022
Pharmac issues RFP for intravenous trastuzumab, a medicine used to treat breast cancer
8 September 2022 - PHARMAC is seeking commercial bids from pharmaceutical suppliers for the supply of intravenous trastuzumab, a ‘biologic’ ...
Posted by Michael Wonder on 07 Sep 2022
Blood cancer patients implore PHARMAC to fund desperately needed medicine
7 September 2022 - New Zealanders living with multiple myeloma are mounting a major, evidence-based campaign to press PHARMAC into funding ...
Posted by Michael Wonder on 02 Sep 2022
Call for Keytruda: Bay of Plenty couple needs help funding hefty cancer treatment
1 September 2022 - Tim Pardy thought he'd beat it. Five months later his pancreatic cancer not only returned, but it ...
Posted by Michael Wonder on 18 Aug 2022
PHARMAC makes cancer treatment available to more people
18 August 2022 - PHARMAC has confirmed today they are widening access from 1 September 2022 to a targeted cancer treatment, ...
Posted by Michael Wonder on 31 Jul 2022
New Zealand Pharmaceutical Schedule - 1 August 2022
1 August 2022 - The August 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 06 Jul 2022
PHARMAC opens door to funding Keytruda in 'biggest step forward in treatment of lung cancer'
6 July 2022 - Keytruda has been called a 'miracle' drug, and there's a glimmer of hope now for those ...
Posted by Michael Wonder on 06 Jul 2022
PHARMAC considering funding new medicines for lung cancer
6 July 2022 - PHARMAC is seeking proposals from pharmaceutical suppliers for medicines that could treat New Zealanders with lung ...